Catch us at an upcoming conference or tradeshow – or sign up for one of our own upcoming events and Benchtalk forums.
Bio-IT World Conference & Expo
April 16, 2019Boston, MA
Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad of IT and informatics applications and enabling technologies that drive biomedical research, drug discovery & development, and clinical and healthcare initiatives. The Bio-IT World Conference & Expo continues to be a vibrant event that unites 3,400+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from 40+ countries.
Each year, the Zhang lab hosts a two-day workshop aimed at sharing knowledge about CRISPR-mediated tools and other aspects of genome engineering, from basic biology to technology development. The workshop is geared toward scientists at all levels of training who have an interest in learning more about implementing genome engineering approaches in their own work and in keeping up with the latest developments in this field.
The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. They bring together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.
Cambridge Healthtech Institute's inaugural World Pharma Week will take place June 17-20 in Boston. Most critical scientifically cutting edge and investment-attractive topics will be discussed at the meeting that includes two well established congresses: the Biomarker World Congress, and the World Preclinical Congress.
The 17th Annual Discovery on Target (DOT), the industry’s preeminent event on novel drug targets and technologies, will convene over 1,300 drug discovery professionals in Boston, MA, on September 16-19, 2019. This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.
SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field. They're dedicated to telling the stories of the field and companies involved, building their networks, and helping them grow.